Do Pharmaceutical Mergers Harm Drug Innovation?

Business & Finance
Cover of the book Do Pharmaceutical Mergers Harm Drug Innovation? by Jan Schmidt, GRIN Verlag
View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart
Author: Jan Schmidt ISBN: 9783656962168
Publisher: GRIN Verlag Publication: May 15, 2015
Imprint: GRIN Verlag Language: English
Author: Jan Schmidt
ISBN: 9783656962168
Publisher: GRIN Verlag
Publication: May 15, 2015
Imprint: GRIN Verlag
Language: English

Master's Thesis from the year 2013 in the subject Business economics - Miscellaneous, grade: 8,5 (NL, äquivalent zu 1,2), Utrecht University (Law, Economics and Governance), course: Mergers & Akquisitions, language: English, abstract: The number and volume of pharmaceutical companies' mergers and acquisitions have reached exorbitant magnitudes in the last decade, with estimations of over 1,300 deals worth US$ 690 billion between 2000 and 2009.1 The biggest transaction, valued at US$ 66.7 billion2, occurred in 2009 when Pfizer bought Wyeth. The sheer dimension of transactions in this sector, being subject to significant public interest, poses questions about the motivations behind these deals, which are mostly believed to be countermeasures for patent expirations, as well as the impact on drug innovation. Even though, the regular object of interest regarding mergers is the shareholder value, in this specific case drug innovation is of particular interest as it does not only influence the future prospects of the pharmaceutical companies but also long term public health. Hence, the objective of this thesis is to discover what the impact of pharmaceutical mergers on R&D intensity and efficiency of the acquiring organization and on the pharmaceutical industry as a whole is.

View on Amazon View on AbeBooks View on Kobo View on B.Depository View on eBay View on Walmart

Master's Thesis from the year 2013 in the subject Business economics - Miscellaneous, grade: 8,5 (NL, äquivalent zu 1,2), Utrecht University (Law, Economics and Governance), course: Mergers & Akquisitions, language: English, abstract: The number and volume of pharmaceutical companies' mergers and acquisitions have reached exorbitant magnitudes in the last decade, with estimations of over 1,300 deals worth US$ 690 billion between 2000 and 2009.1 The biggest transaction, valued at US$ 66.7 billion2, occurred in 2009 when Pfizer bought Wyeth. The sheer dimension of transactions in this sector, being subject to significant public interest, poses questions about the motivations behind these deals, which are mostly believed to be countermeasures for patent expirations, as well as the impact on drug innovation. Even though, the regular object of interest regarding mergers is the shareholder value, in this specific case drug innovation is of particular interest as it does not only influence the future prospects of the pharmaceutical companies but also long term public health. Hence, the objective of this thesis is to discover what the impact of pharmaceutical mergers on R&D intensity and efficiency of the acquiring organization and on the pharmaceutical industry as a whole is.

More books from GRIN Verlag

Cover of the book Der Punk und das Dao. Einheit oder Gegensatz? by Jan Schmidt
Cover of the book Internationale Kartellzivilverfahren und ausländische Unternehmen by Jan Schmidt
Cover of the book Der Fall Konstantinopels und die vermeintliche Türkengefahr by Jan Schmidt
Cover of the book Vergleich fremdenfeindlicher und antisemitischer Einstellungsprofile in Europa by Jan Schmidt
Cover of the book Does Mukundan in Anita Nair's novel 'The Better Man' become a better man? by Jan Schmidt
Cover of the book Intrinsische und extrinsische Eigenschaften von Kunstwerken in Nelson Goodmans Frage nach der Rolle des Symbolischen in der Kunst by Jan Schmidt
Cover of the book Die Entwicklungsgeschichte des Sportkletterns in der Sächsischen Schweiz by Jan Schmidt
Cover of the book Unternehmensüberwachung in der Europäischen Gesellschaft ('Societas Europaea') by Jan Schmidt
Cover of the book Eingangsrechnungen sachlich und rechnerisch prüfen (Unterweisung Bürokaufmann / -frau) by Jan Schmidt
Cover of the book Gibt es eine Transformation der Machtverhältnisse im Bereich ökonomischer Eliten? by Jan Schmidt
Cover of the book U. K.-Limited vs. GmbH - Reformierung der GmbH zur Beschränkung des Gründungsbooms der Ltd.? by Jan Schmidt
Cover of the book Welche Faktoren tragen dazu bei, um von einer Kritik am Sozialstaat sprechen zu können und ihn in einer Krise erscheinen zu lassen? by Jan Schmidt
Cover of the book Blumenproduktion in Kolumbien - Ein Fall von Wirtschaftssklaverei? by Jan Schmidt
Cover of the book Der Einsatz von Experten in der Kriegsberichterstattung am Beispiel des dritten Golfkrieges by Jan Schmidt
Cover of the book Was können wir über die Welt wissen? by Jan Schmidt
We use our own "cookies" and third party cookies to improve services and to see statistical information. By using this website, you agree to our Privacy Policy